FindTrial
Sign In

NiCord®

DRUG2 trials

Sponsors

Gamida Cell ltd

Conditions

Acute Lymphoblastic Leukemia (ALL)Acute Myelogenous Leukemia (AML)Acute Myeloid Leukemia (AML)Hematological MalignanciesHodgkin's DiseaseMyelodysplastic Syndrome (MDS)Non-Hodgkin's Lymphoma

Phase 1

Pilot Study Evaluating Safety & Efficacy of DCBT: NiCord® & UNM CBU to Patients With Hematological Malignancies
CompletedNCT01221857
Gamida Cell ltdAcute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML), Hodgkin's Disease +2
Start: 2010-11-30End: 2013-05-31Updated: 2021-08-03
Transplantation of NiCord®, Umbilical Cord Blood-derived Ex Vivo Expanded Cells, in Patients With HM
CompletedNCT01816230
Gamida Cell ltdAcute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Hematological Malignancies +1
Start: 2013-04-30End: 2018-06-30Updated: 2020-10-22

Related Papers

NiCord single unit expanded umbilical cord blood transplantation: Results of phase I/II trials.
Journal of Clinical Oncology2016-05-203 citations
Umbilical cord blood expansion with nicotinamide provides long-term multilineage engraftment.
2014-06-09190 citations